# APRISO
> **NDA022301** · New Drug Application · Sponsor: SALIX · Approved 2008-10-31
## Drug
- **FDA Application Number:** NDA022301
- **Application type:** New Drug Application
- **Brand name:** APRISO
- **Generic name:** MESALAMINE
- **Active ingredients:** MESALAMINE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SALIX
- **Manufacturer:** Teva Pharmaceuticals USA, Inc.
- **First approval:** 2008-10-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022301)
---
*MORVS · CC0 1.0*